Gv 2017 Gp, L.L.C.

Insider Reports History

Location: 1600 Amphitheatre Parkway, Mountain View, CA
Signature: /s/ Inga Goldbard, General Counsel of GV 2017 GP, L.L.C.
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gv 2017 Gp, L.L.C.:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Gitlab Inc.	10%+ Owner	Class B Common Stock	8.89M	$561M	$63.12	Oct 18, 2021	By GV 2017, L.P.
Verve Therapeutics, Inc.	Member of 10% Group	Common Stock	6.11M	$61.1M	$10.00	Nov 4, 2022	By GV 2017 L.P.
Verve Therapeutics, Inc.	Member of 10% Group	Common Stock	4.26M	$42.6M	$10.00	Nov 4, 2022	By GV 2019 L.P.
Gitlab Inc.	10%+ Owner	Series C Preferred Stock	0			Oct 18, 2021	By GV 2017, L.P.
Gitlab Inc.	10%+ Owner	Series D Preferred Stock	0			Oct 18, 2021	By GV 2017, L.P.
Verve Therapeutics, Inc.	Member of 10% Group	Common Stock	0		$10.00	Nov 4, 2022	By Alphabet Holdings LLC
Verve Therapeutics, Inc.	Member of 10% Group	Series A Preferred Stock	0			Jun 21, 2021	By GV 2017, L.P.

Showing 1 to 7 of 7 entries

Insider Reports Filed by Gv 2017 Gp, L.L.C.

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
VERV	Verve Therapeutics, Inc.	Nov 4, 2022	7	-$3.03M	4	Nov 8, 2022	Member of 10% Group
VERV	Verve Therapeutics, Inc.	Nov 2, 2022	14	-$5.31M	4	Nov 4, 2022	Member of 10% Group
VERV	Verve Therapeutics, Inc.	Oct 31, 2022	16	-$6.5M	4	Nov 2, 2022	Member of 10% Group
GTLB	Gitlab Inc.	Oct 18, 2021	3	$0	4	May 6, 2022	10%+ Owner
GTLB	Gitlab Inc.	Oct 13, 2021	0	$0	3	May 6, 2022	10%+ Owner
VERV	Verve Therapeutics, Inc.	Jun 21, 2021	2	$0	4	Jun 22, 2021	10%+ Owner
VERV	Verve Therapeutics, Inc.	Jun 16, 2021	0	$0	3	Jun 16, 2021	10%+ Owner